Heba Abdelrasheed Allam

511 total citations
29 papers, 420 citations indexed

About

Heba Abdelrasheed Allam is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Heba Abdelrasheed Allam has authored 29 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Organic Chemistry, 20 papers in Molecular Biology and 9 papers in Pharmacology. Recurrent topics in Heba Abdelrasheed Allam's work include Synthesis and biological activity (12 papers), Cholinesterase and Neurodegenerative Diseases (9 papers) and Enzyme function and inhibition (8 papers). Heba Abdelrasheed Allam is often cited by papers focused on Synthesis and biological activity (12 papers), Cholinesterase and Neurodegenerative Diseases (9 papers) and Enzyme function and inhibition (8 papers). Heba Abdelrasheed Allam collaborates with scholars based in Egypt, Italy and United States. Heba Abdelrasheed Allam's co-authors include Hany S. Ibrahim, Claudiu T. Supuran, Hatem A. Abdel‐Aziz, Walaa R. Mahmoud, Ahmed M. El Kerdawy, Alessio Nocentini, Alessandro Bonardi, Doaa E. Abdel Rahman, Riham F. George and Kamilia M. Amin and has published in prestigious journals such as European Journal of Medicinal Chemistry, Bioorganic Chemistry and Journal of Enzyme Inhibition and Medicinal Chemistry.

In The Last Decade

Heba Abdelrasheed Allam

25 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Heba Abdelrasheed Allam Egypt	12	322	235	97	58	44	29	420
Walaa R. Mahmoud Egypt	13	328 1.0×	240 1.0×	89 0.9×	39 0.7×	56 1.3×	25	417
Rofaida Salem Egypt	10	266 0.8×	217 0.9×	57 0.6×	23 0.4×	39 0.9×	16	343
Omaima M. Abdelhafez Egypt	12	407 1.3×	194 0.8×	117 1.2×	42 0.7×	48 1.1×	17	548
Simone Giovannuzzi Italy	13	326 1.0×	351 1.5×	119 1.2×	20 0.3×	29 0.7×	70	475
Adrián Puerta Spain	13	326 1.0×	181 0.8×	74 0.8×	36 0.6×	55 1.3×	46	479
Safinaz E. Abbas Egypt	12	537 1.7×	226 1.0×	72 0.7×	31 0.5×	50 1.1×	19	619
Afaf El‐Malah Egypt	14	308 1.0×	145 0.6×	105 1.1×	45 0.8×	41 0.9×	27	434
Haytham O. Tawfik Egypt	19	434 1.3×	329 1.4×	83 0.9×	59 1.0×	102 2.3×	56	694
Andrea Petreni Italy	12	291 0.9×	320 1.4×	84 0.9×	11 0.2×	29 0.7×	21	383
Amal A.M. Eissa Egypt	10	309 1.0×	110 0.5×	80 0.8×	24 0.4×	40 0.9×	11	372

Countries citing papers authored by Heba Abdelrasheed Allam

Since Specialization

Citations

This map shows the geographic impact of Heba Abdelrasheed Allam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heba Abdelrasheed Allam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heba Abdelrasheed Allam more than expected).

Fields of papers citing papers by Heba Abdelrasheed Allam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heba Abdelrasheed Allam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heba Abdelrasheed Allam. The network helps show where Heba Abdelrasheed Allam may publish in the future.

Co-authorship network of co-authors of Heba Abdelrasheed Allam

This figure shows the co-authorship network connecting the top 25 collaborators of Heba Abdelrasheed Allam. A scholar is included among the top collaborators of Heba Abdelrasheed Allam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heba Abdelrasheed Allam. Heba Abdelrasheed Allam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Allam, Heba Abdelrasheed, Ishaq Khan, Tamer E. Fandy, et al.. (2025). Design, novel one-pot green synthesis, and biological evaluation of pyrazolopyridine-congeners selectively targeting HER2+ breast cancer. Bioorganic Chemistry. 163. 108681–108681.

Moussa, Ahmed, et al.. (2025). Design and development of potent roflumilast analogues targeting PDE-4B: selectivity and pharmacokinetic insights. Bioorganic Chemistry. 167. 109201–109201.

Saleh, Noureldin, et al.. (2025). 6,7-Dimethoxy-2-methyl-4-substituted quinazolines: Design, synthesis, EGFR inhibitory activity, in vitro cytotoxicity, and in silico studies. European Journal of Medicinal Chemistry. 290. 117502–117502.

El-Sayed, Nahed N. E., et al.. (2025). Quinolone as a Privileged Scaffold: A Brief Overview on Early Classical and Recent Advanced Synthetic Pathways, Innovative Neuroprotective Potential, and Structure‐Activity Relationships. Drug Development Research. 86(5). e70132–e70132.

Allam, Heba Abdelrasheed, Marwa A. Fouad, Ahmed M. El Kerdawy, et al.. (2024). Discovery of novel quinolin-2-one derivatives as potential GSK-3β inhibitors for treatment of Alzheimer’s disease: Pharmacophore-based design, preliminary SAR, in vitro and in vivo biological evaluation. Bioorganic Chemistry. 146. 107324–107324. 12 indexed citations

Allam, Heba Abdelrasheed, et al.. (2024). Design, synthesis, and biological evaluation of dinaciclib and CAN508 hybrids as CDK inhibitors. Drug Development Research. 85(3). e22193–e22193. 1 indexed citations

Moussa, Ahmed, et al.. (2024). Rationale design and synthesis of new roflumilast analogues as preferential selective and potent PDE-4B inhibitors. Bioorganic Chemistry. 153. 107911–107911. 3 indexed citations

Allam, Heba Abdelrasheed, et al.. (2023). Arylidine extensions of 3-methyl-5-oxo-4,5-dihydro-1H-pyrazol-benzenesulfonamide derivatives: Synthesis, computational simulations and biological evaluation as tumor-associated carbonic anhydrase inhibitors. Bioorganic Chemistry. 135. 106492–106492. 6 indexed citations

Allam, Heba Abdelrasheed, Walaa R. Mahmoud, Alessandro Bonardi, et al.. (2023). Effect of hydrophobic extension of aryl enaminones and pyrazole-linked compounds combined with sulphonamide, sulfaguanidine, or carboxylic acid functionalities on carbonic anhydrase inhibitory potency and selectivity. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 2201403–2201403. 6 indexed citations

10.

Rahman, Doaa E. Abdel, et al.. (2023). Novel VEGFR-2 inhibitors as antiangiogenic and apoptotic agents via paracrine and autocrine cascades: Design, synthesis, and biological evaluation. Bioorganic Chemistry. 139. 106678–106678. 3 indexed citations

11.

Allam, Heba Abdelrasheed, et al.. (2023). One-pot three-component synthesis, in vitro anticancer activity and p53-MDM2 protein-protein interaction inhibition of novel spiro-oxindoline-based pyrazolo[3,4-b]pyridines. Egyptian Journal of Chemistry. 0(0). 0–0. 3 indexed citations

12.

Allam, Heba Abdelrasheed, et al.. (2023). Design and synthesis of certain 7-Aryl-2-Methyl-3-Substituted Pyrazolo{1,5-a}Pyrimidines as multikinase inhibitors. European Journal of Medicinal Chemistry. 262. 115918–115918. 12 indexed citations

13.

Allam, Heba Abdelrasheed, et al.. (2022). Design, synthesis, cytotoxic and enzyme inhibitory activities of 1,3,4-oxadiazole and 1,3,4-thiadiazine hybrids against non-small cell lung cancer. Results in Chemistry. 4. 100373–100373. 3 indexed citations

14.

Allam, Heba Abdelrasheed, et al.. (2022). Design and synthesis of some new 6-bromo-2-(pyridin-3-yl)-4-substituted quinazolines as multi tyrosine kinase inhibitors. Bioorganic Chemistry. 128. 106099–106099. 15 indexed citations

15.

Ahmed, Mahmoud S., Heba Abdelrasheed Allam, Ramzia I. El‐Bagary, et al.. (2021). 3-Methyl-imidazo[2,1-b]thiazole derivatives as a new class of antifolates: Synthesis, in vitro/in vivo bio-evaluation and molecular modeling simulations. Bioorganic Chemistry. 115. 105205–105205. 9 indexed citations

16.

Amin, Kamilia M., et al.. (2021). Design and synthesis of novel coumarin derivatives as potential acetylcholinesterase inhibitors for Alzheimer's disease. Bioorganic Chemistry. 110. 104792–104792. 36 indexed citations

17.

Eldehna, Wagdy M., Rofaida Salem, Alessandro Bonardi, et al.. (2021). Natural inspired ligustrazine-based SLC-0111 analogues as novel carbonic anhydrase inhibitors. European Journal of Medicinal Chemistry. 228. 114008–114008. 23 indexed citations

18.

Eissa, Amal A.M., et al.. (2021). Design and synthesis of novel pyridopyrimidine derivatives with anchoring non-coplanar aromatic extensions of EGFR inhibitory activity. Bioorganic Chemistry. 116. 105318–105318. 24 indexed citations

19.

Allam, Heba Abdelrasheed, Mahmoud F. Abo-Ashour, Alessio Nocentini, et al.. (2019). Application of hydrazino and hydrazido linkers to connect benzenesulfonamides with hydrophilic/phobic tails for targeting the middle region of human carbonic anhydrases active site: Selective inhibitors of hCA IX. European Journal of Medicinal Chemistry. 179. 547–556. 25 indexed citations

20.

Ibrahim, Hany S., Heba Abdelrasheed Allam, Walaa R. Mahmoud, et al.. (2018). Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: Selective inhibitors for the tumor-associated hCA IX isoform. European Journal of Medicinal Chemistry. 152. 1–9. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact